Hundreds of codes, one fee schedule, and no way to see which lines still clear.
A broad menu means your fee-schedule exposure is spread across hundreds of codes. The preliminary CY2027 rates are posted, so the question is no longer whether rates moved: it is which of your lines stopped covering their cost, and nobody can answer that from a spreadsheet in the week it matters.
What the model does with your menu
- Load a published fee schedule and see the whole menu re-priced, per code and per assay.
- Menu triage ranks every assay by what moved, flags the ones that fall below variable cost, and exports as one board file.
- Send-out economics for the long tail: insource vs. reference-lab price, with the break-even volume.
- Assay launch and ramp costed through the low-volume trough, not just at steady state.
The sample lab you can explore today is a molecular lab, not a broad-menu one. The economics and every screen are the same, the menu is not. A broad-menu sample lab is on the roadmap; until then the fastest honest route is your own menu, which is what onboarding does with you.
Your archetype is a starting point, not a cage
If your lab sits on the border between two of these (most independent labs do) pick whichever is closest. Setup starts you with a lean set of capabilities for that archetype, and every other capability is a free switch you turn on until the model fits. Nothing is behind a tier, and nothing you turn on can be taken away by the choice you made on day one.
Built for the molecular lab: molecular IVD (PCR, syndromic panels, infectious disease) and clinical genomics. The same unit economics extend to broader-menu labs, but the molecular lab is who we build for.